Related Topics News -

     
 Detail   |   Print    Next page > 
     
《業績》艾美疫苗去年虧損擴大至6.75億元人民幣
2026-03-31T  
艾美疫苗全球首研無血清迭代狂犬疫苗通過註冊現場檢查
2026-02-06T  
艾美疫苗20價肺炎球菌疫苗獲准開展臨床試驗
2026-01-19T  
艾美疫苗人二倍體狂犬疫苗完成三期臨床現場工作
2026-01-15T  
國家衛健委建議每年接種流感疫苗
2026-01-13T  
《業績》艾美疫苗中期虧損收窄至1.31億人民幣
2025-08-28T  
艾美疫苗mRNA帶狀皰疹疫苗獲批在中國開展臨床試驗
2025-05-19T  
艾美疫苗委任總裁
2025-04-22T  
艾美疫苗無血清迭代狂犬疫苗上市註冊獲受理
2025-04-08T  
《業績》艾美疫苗全年虧損收窄至2.77億人民幣
2025-03-30T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.